West Virginia 2022 Regular Session

West Virginia House Bill HB2311

Introduced
1/12/22  

Caption

Requiring prescriptions be made by electronic means

Impact

The implementation of HB 2311 is expected to significantly impact the pharmaceutical landscape in West Virginia. By enforcing mandatory e-prescribing, the bill seeks to reduce prescription errors and enhance data management in pharmacies. This could lead to improved patient safety and streamlined processes for healthcare providers. However, there are concerns regarding access to technology, particularly in rural areas where not all practitioners may be equipped to meet the new requirements, potentially leading to disparities in care.

Summary

House Bill 2311 aims to mandate that all prescriptions issued in the state of West Virginia be made electronically, effective July 1, 2021. This legislation seeks to modernize the prescribing process, transitioning away from traditional written, oral, or fax prescriptions. The bill presents various exceptions where electronic prescribing will not be required, such as prescriptions issued by veterinarians, those dispensed by entities within specific regulatory criteria, and under circumstances where electronic methods are temporarily unavailable. Overall, the bill aligns with advancements in healthcare technology and intends to foster more efficient and secure prescription practices.

Sentiment

The sentiment surrounding HB 2311 is mixed. Supporters argue that the shift to electronic prescriptions will enhance patient safety and improve the efficiency of healthcare delivery. They highlight that e-prescribing reduces the risk of misinterpretation associated with handwritten prescriptions. Conversely, opponents of the bill are worried about the feasibility of enforcing such a mandate, particularly its implications for practitioners working in less technologically advanced settings. Critics voice concerns over potential barriers to care for patients who may require flexibility in their prescribing practices.

Contention

Notable points of contention include the bill's lack of provisions for practitioners who may face challenges in transitioning to electronic methods. The outlined exceptions appear designed to mitigate some concerns, but many stakeholders still question whether these exceptions are comprehensive enough. Additionally, there may be pushback regarding the costs associated with implementing the necessary technology for compliance, particularly for smaller practices and rural providers.

Companion Bills

No companion bills found.

Similar Bills

CA AB852

Health care practitioners: electronic prescriptions.

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

AZ HB2291

Opioids; containers; labeling; requirements; repeal

AZ SB1254

Opioids; containers; labeling; requirements; repeal

LA HB548

Requires that the prescribers transmit prescriptions for opioids to pharmacies electronically (EG SEE FISC NOTE SG EX See Note)

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

TX HB2174

Relating to controlled substance prescriptions and reimbursement for treatment for certain substance use disorders; authorizing a fee.

TX SB1233

Relating to controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.